Aging
Navigate
Submit an Article
Research Paper|Volume 15, Issue 17|pp. 8744–8769
Comprehensive analysis and experimental validation reveal elevated CLCN4 is a promising biomarker in endometrial cancer
Back to articleFigure 8(8 of 14)
100%
Figure 8
Figure 8.Correlation of CLCN4 expression with microsatellite instability (MSI) and tumor mutational burden (TMB). (A) Correlation between ClCN4 and MSI. (B) Correlation between CLCN4 and TMB.